Literature DB >> 8940297

Human intestinal trefoil factor is expressed in human hypothalamus and pituitary: evidence for a novel neuropeptide.

J C Probst1, T Zetzsche, M Weber, P Theilemann, T Skutella, R Landgraf, G F Jirikowski.   

Abstract

Human intestinal trefoil factor, hITF, a secretory polypeptide found mainly in the human gastrointestinal tract, is a member of the newly characterized trefoil factor or P-domain peptide family representing putative growth factors. Here we describe the identification of this gut peptide in the human brain and pituitary. With reverse transcriptase polymerase chain reaction, we were able to isolate and clone the transcript from human hypothalamus. An antibody generated against a synthetic peptide derived from the carboxyl terminus of hITF was used for immunohistochemical studies of appropriate tissue sections. Neurons expressing hITF were identified in two magnocellular hypothalamic nuclei, the paraventricular and periventricular nuclei. hITF polypeptide was also observed in Herring bodies of the neurohypophysis and in secretory cells of the adenohypophysis. Double immunostaining with antigrowth hormone antibody showed partial coexistence in a selected subpopulation of adenohypophysial cells. Localization of hITF in the hypothalamo-neurohypophysial system may suggest a modulatory action on the classical magnocellular nonapeptides vasopressin and oxytocin, and further indicates an adenohypophysial importance of this peptide. It is likely that hITF represents a novel neuropeptide of yet unknown function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940297     DOI: 10.1096/fasebj.10.13.8940297

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  11 in total

1.  Goblet-cell-specific transcription of mouse intestinal trefoil factor gene results from collaboration of complex series of positive and negative regulatory elements.

Authors:  H Itoh; N Inoue; D K Podolsky
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

Review 2.  Structure, Function, and Therapeutic Potential of the Trefoil Factor Family in the Gastrointestinal Tract.

Authors:  Nayara Braga Emidio; Stuart M Brierley; Christina I Schroeder; Markus Muttenthaler
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-09

3.  PI3K/Akt signaling pathway in the basolateral amygdala mediates the rapid antidepressant-like effects of trefoil factor 3.

Authors:  Hai-Shui Shi; Wei-Li Zhu; Jian-Feng Liu; Yi-Xiao Luo; Ji-Jian Si; Shen-Jun Wang; Yan-Xue Xue; Zeng-Bo Ding; Jie Shi; Lin Lu
Journal:  Neuropsychopharmacology       Date:  2012-07-25       Impact factor: 7.853

4.  Trefoil factor-3 expression in human colon cancer liver metastasis.

Authors:  Mark Babyatsky; Jing Lin; Xianyang Yio; Anli Chen; Jie-yu Zhang; Yan Zheng; Christina Twyman; Xiuliang Bao; Myron Schwartz; Swan Thung; J Lawrence Werther; Steven Itzkowitz
Journal:  Clin Exp Metastasis       Date:  2008-11-02       Impact factor: 5.150

5.  Altered expression of securin (Pttg1) and serpina3n in the auditory system of hearing-impaired Tff3-deficient mice.

Authors:  M Lubka-Pathak; A A Shah; M Gallozzi; M Müller; U Zimmermann; H Löwenheim; M Pfister; M Knipper; N Blin; T Schimmang
Journal:  Cell Mol Life Sci       Date:  2010-11-15       Impact factor: 9.261

6.  Trefoil factor 3 as an endocrine neuroprotective factor from the liver in experimental cerebral ischemia/reperfusion injury.

Authors:  Shu Q Liu; Derek Roberts; Brian Zhang; Yupeng Ren; Li-Qun Zhang; Yu H Wu
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

7.  Plasma proteomic signatures predict dementia and cognitive impairment.

Authors:  Toshiko Tanaka; Robert Lavery; Vijay Varma; Giovanna Fantoni; Marco Colpo; Madhav Thambisetty; Julian Candia; Susan M Resnick; David A Bennett; Angelique Biancotto; Stefania Bandinelli; Luigi Ferrucci
Journal:  Alzheimers Dement (N Y)       Date:  2020-05-09

8.  Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas.

Authors:  E Bignotti; A Ravaggi; R A Tassi; S Calza; E Rossi; M Falchetti; C Romani; E Bandiera; F E Odicino; S Pecorelli; A D Santin
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

9.  Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals.

Authors:  R W Paterson; J W Bartlett; K Blennow; N C Fox; L M Shaw; J Q Trojanowski; H Zetterberg; J M Schott
Journal:  Transl Psychiatry       Date:  2014-07-29       Impact factor: 6.222

10.  Trefoil Factor 3, Cholinesterase and Homocysteine: Potential Predictors for Parkinson's Disease Dementia and Vascular Parkinsonism Dementia in Advanced Stage.

Authors:  Jing Zou; Zhigang Chen; Caiqian Liang; Yongmei Fu; Xiaobo Wei; Jianjun Lu; Mengqiu Pan; Yue Guo; Xinxue Liao; Huifang Xie; Duobin Wu; Min Li; Lihui Liang; Penghua Wang; Qing Wang
Journal:  Aging Dis       Date:  2018-02-01       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.